ClinicalTrials.Veeva

Menu

The Effect of Acupoint Application on Postoperative Ileus

L

li xiong

Status

Unknown

Conditions

Postoperative Ileus

Treatments

Other: Acupoint application
Other: Fake acupoint application

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims to verify the therapeutical effect and mechanism of acupoint application on postoperative ileus.

Full description

Postoperative ileus (POI) is a common disorder of gastrointestinal motility characterized by abdominal distension, nausea, vomiting and delayed passage of flatus or stool, which develops after every abdominal surgical procedure. POI increases risk of developing postoperative complications, decreases the bed turnover rate and prolongs the average duration of hospitalization, increasing the expense of both patients and hospitals. Although the Pathophysiological mechanism of POI remains unclear, recent researches suggests the inflammatory responses after surgery might be responsible for the gastrointestinal motility disorder. Acupoint application is a traditional chinese intervention which has been used in treating gastrointestinal motility disorder resulted from other causes. In this study, we aims to verify the therapeutical effect and mechanism of acupoint application on postoperative ileus.

Enrollment

540 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Patients are scheduled to undergo elective abdominal surgery;
    1. Patients age between 20 to 80 years old;
    1. Umbilical skin condition is good;
    1. Written informed consent provided to participate in the study.

Exclusion criteria

  • 1.Patients don't match the inclusion criteria;
    1. Patients with severe comorbidity such as cardiac disease, liver disease, pulmonary disease or renal disease ;
  • 3.Patients with mental disorder;
    1. Patients have gastrointestinal mobility disorder resulted from clear causes, such as ankylenteron, ascites, etc;
    1. Patients received ostomy operation, such as jejunostomy;
  • 6.Patients who have history of abdominal surgery or history of bowel obstruction;
    1. Patients who receive other treatments to improve the gastrointestinal mobility or/and to relieve POI related symptoms , such as gastrointestinal prokinetic drugs, enema, etc.
    1. Patients who are allergic to the acupoint applicaton;
  • 9.Patients who are unsuitable for study inclusion as determined by the investigator. (eg: patients with severe operation related complications)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

540 participants in 3 patient groups, including a placebo group

Intervention arm
Experimental group
Description:
Receiving the acupoint application and optimal supports. The patients start using the acupoint application on the umbilical Shenque point in 2 hours after surgery, 1 or 2 times a day, lasting 5 days. All patients will receive optimal supports during the observation period, including preoperative gastrointestinal preparation, inserting gastric tube, postoperative fasting, necessary antibiotic use, rational fluid management, detaining drainage tube, etc.
Treatment:
Other: Acupoint application
Placebo arm
Placebo Comparator group
Description:
Receiving the fake acupoint application and optimal supports. The fake acupoint is The patients start using the fake acupoint application on the umbilical Shenque point in 2 hours after surgery, 1 or 2 times a day, lasting 5 days. All patients will receive optimal supports during the observation period, including preoperative gastrointestinal preparation, inserting gastric tube, postoperative fasting, necessary antibiotic use, rational fluid management, detaining drainage tube, etc.
Treatment:
Other: Fake acupoint application
Control arm
No Intervention group
Description:
Receiving the optimal supports. All patients will receive optimal supports during the observation period, including preoperative gastrointestinal preparation, inserting gastric tube, postoperative fasting, necessary antibiotic use, rational fluid management, detaining drainage tube, etc.

Trial contacts and locations

1

Loading...

Central trial contact

xiong Li, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems